Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Bempedoic Acid/Ezetimibe/High-intensity Statin on Plaque Regression and Stabilisation of Coronary Atherosclerosis Among Patients Without Cardiovascular Events

NCT07474649 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT07474649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07474649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Bempedoic Acid/Ezetimibe/High-intensity Statin on Plaque Regression and Stabilisation of Coronary Atherosclerosis Among Patients Without Cardiovascular Events
Lead sponsor
Daiichi Sankyo
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
October 2, 2028
Enrollment
103 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

coronary atherosclerosis, hypercholesterolemia, mixed dyslipidemia